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Abstract 
Urinary alpha1-microglobulin (a1M) in people is a biomarker of renal tubular damage (Bazzi, 2001), but 
it has not yet been used in cats with chronic kidney disease (CKD). 
The aim of this study was to validate an ELISA test marketed for the measurement of feline a1M. 
Thirty-four urine supernatants collected from cats affected by or at risk for CKD were assayed by SDS-
AGE, to classify patients according to presence or absence of low molecular weight proteinuria 
suggestive of tubular damage. 
Two samples with and one without tubular bands were used to evaluate intra-assay variability, linearity 
under dilution (LUD) and spiking recovery test (SRT) of the ELISA. Then, a1M concentration was 
measured in samples with (n°=10) or without (n°=25) tubular bands. The standard solution included in 
the kit was also assayed by SDS-AGE. 
The intra-assay CVs was >20%. LUD and SRT showed that the test is not accurate. No significant 
difference was found between a1M concentration in samples with and without tubular bands (median 
values: 35.19 and 40.83 μg/mL respectively). SDS-AGE on the standard solution failed to identify bands 
with molecular weight consistent with a1M but showed the presence of albumin. 
Results of this investigation did not support the use of this test to measure a1M in cats likely due to the 
absence of a1M in the standard solution provided with the kit.  
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